Intel rose 5.4% after SoftBank’s $2 billion investment, while Nvidia dipped slightly despite price target hikes ahead of earnings. Twilio climbed after joining the S&P MidCap 400, and Palo Alto gained nearly 5% on strong results and guidance. Pfizer edged higher as Canada approved its updated COVID-19 vaccine, offsetting last week’s trial setback, amid active after-hours trading.